Anyone else think Monil Shah renumeration is a bit rich..?
He gets $190K bonus for signing a pre clinical partnership for OnCARlytic's. That was it to meet his KPI.
Current T cell therapy can only go after blood cancers. I cant see the difficultly or "work" required to get a partner for mouse models on solid tumours. And correct me if I am wrong, but aren't we covering our own costs in this partnership?
Given his $595K static salary. In my opinion if he hasn't generated any revenue for the company he should not be inline to receive a bonus.
He's also paid in a fixed USD amount. If the Ozzie tumbles he'll end up getting more then Leslie at this rate.
Hate to think what his bonus would be if he actually signs a commercial deal.
Ann: Annual Report to shareholders, page-30
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.004(7.14%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 6.1¢ | 5.6¢ | $1.091M | 18.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1119449 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 944936 | 17 |
View Market Depth
| Last trade - 15.33pm 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |